RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CHATTARAGADA MS
Collezione AOU Città della Salute di Torino

Items : 5

FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis. in Oncogene / Oncogene. 2018 Feb 8;37(6):697-709. doi: 10.1038/onc.2017.358. Epub 2017 Oct 23.

2018
AOU Città della Salute di Torino

Scarpa A; Rusev B; Salvia R; Allavena P; Evangelista A; Curcio C; Santamorena MM; Roux C; Sassoe M; Principe M; Riganti C; Chattaragada MS; Cappello P; Novelli F;

Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. in Journal of hematology & oncology / J Hematol Oncol. 2017 Jan 13;10(1):16. doi: 10.1186/s13045-016-0385-8.

2017
AOU Città della Salute di Torino

Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F;

Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies. in Translational research : the journal of laboratory and clinical medicine / Transl Res. 2016 May;171:17-28.e1-2. doi: 10.1016/j.trsl.2015.12.013. Epub 2015 Dec 23.

2016
AOU Città della Salute di Torino

Alessio M; Novelli F; Amedei A; De Monte L; Álvarez-Fernández SM; Mautino A; Cassoni P; Ciccone G; Castiglione A; Alushi B; Chattaragada MS; Vallone R; Capello M; Caorsi C; Niccolai E;

Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. in Oncotarget / Oncotarget. 2016 Feb 2;7(5):5598-612. doi: 10.18632/oncotarget.6798.

2016
AOU Città della Salute di Torino

Capello M; Ferri-Borgogno S; Riganti C; Chattaragada MS; Principe M; Roux C; Zhou W; Petricoin EF; Cappello P; Novelli F;

Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells. in Oncotarget / Oncotarget. 2015 May 10;6(13):11098-113. doi: 10.18632/oncotarget.3572.

2015
AOU Città della Salute di Torino

Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F;